| Entry |
|
|---|
| Name |
Iproniazid phosphate;
Marsilid (TN) |
|---|
| Formula |
C9H13N3O. H3PO4
|
|---|
| Exact mass |
277.0828
|
|---|
| Mol weight |
277.2142
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
|
|---|
| Remark |
|
|---|
| Efficacy |
Antidepressant, Monoamine oxidase (MAO) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa00260 | Glycine, serine and threonine metabolism |
| hsa00330 | Arginine and proline metabolism |
| hsa00982 | Drug metabolism - cytochrome P450 |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AF Monoamine oxidase inhibitors, non-selective
N06AF05 Iproniazide
D08085 Iproniazid phosphate
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00950 Iproniazide
D08085 Iproniazid phosphate
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAO
D08085 Iproniazid phosphate
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00950 Iproniazide
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 18
1 C8y C 13.9300 -17.9200
2 C5a C 15.1900 -18.6200
3 C8x C 12.7400 -18.6200
4 C8x C 13.9300 -16.5200
5 N1b N 16.3800 -17.9200
6 O5a O 15.1900 -20.0200
7 C8x C 11.5500 -17.9200
8 C8x C 12.7400 -15.8200
9 N1b N 17.5700 -18.6200
10 N5x N 11.5500 -16.5200
11 C1c C 18.8300 -17.9200
12 C1a C 20.0200 -18.6200
13 C1a C 18.8300 -16.5200
14 P1b P 25.4800 -17.5000
15 O1c O 25.4800 -16.1000
16 O1c O 24.0800 -17.5000
17 O1c O 26.8800 -17.5000
18 O1c O 25.4800 -18.9000
BOND 17
1 1 4 1
2 2 5 1
3 2 6 2
4 3 7 1
5 4 8 2
6 5 9 1
7 7 10 2
8 8 10 1
9 9 11 1
10 1 2 1
11 11 12 1
12 1 3 2
13 11 13 1
14 14 15 2
15 14 16 1
16 14 17 1
17 14 18 1
|
|---|
